BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16251199)

  • 1. A segment of the Mecp2 promoter is sufficient to drive expression in neurons.
    Adachi M; Keefer EW; Jones FS
    Hum Mol Genet; 2005 Dec; 14(23):3709-22. PubMed ID: 16251199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
    Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
    Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
    Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2.
    Tsujimura K; Abematsu M; Kohyama J; Namihira M; Nakashima K
    Exp Neurol; 2009 Sep; 219(1):104-11. PubMed ID: 19427855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cis-regulatory elements for MECP2 expression.
    Liu J; Francke U
    Hum Mol Genet; 2006 Jun; 15(11):1769-82. PubMed ID: 16613900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a murine methyl cytosine phosphate guanine binding domain-containing factor 3 (MBD3) promoter segment sufficient for driving reporter gene expression in neurons in vitro and in vivo.
    Jung BP; Purushotham D; Eubanks JH
    Neuroscience; 2007 Mar; 145(3):1016-25. PubMed ID: 17289276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2 in neurons: closing in on the causes of Rett syndrome.
    Caballero IM; Hendrich B
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M; Zoghbi HY
    Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex.
    Akbarian S; Chen RZ; Gribnau J; Rasmussen TP; Fong H; Jaenisch R; Jones EG
    Neurobiol Dis; 2001 Oct; 8(5):784-91. PubMed ID: 11592848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MeCP2 mutant protein is expressed in astrocytes as well as in neurons and localizes in the nucleus.
    Kifayathullah LA; Arunachalam JP; Bodda C; Agbemenyah HY; Laccone FA; Mannan AU
    Cytogenet Genome Res; 2010; 129(4):290-7. PubMed ID: 20625242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
    Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
    Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J; Wu H; Sun YE
    Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
    Jung BP; Jugloff DG; Zhang G; Logan R; Brown S; Eubanks JH
    J Neurobiol; 2003 Apr; 55(1):86-96. PubMed ID: 12605461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
    Nag N; Mellott TJ; Berger-Sweeney JE
    Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions.
    Kishi N; Macklis JD
    Mol Cell Neurosci; 2004 Nov; 27(3):306-21. PubMed ID: 15519245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice.
    Pelka GJ; Watson CM; Radziewic T; Hayward M; Lahooti H; Christodoulou J; Tam PP
    Brain; 2006 Apr; 129(Pt 4):887-98. PubMed ID: 16467389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.